Publications by authors named "Stephen John Proctor"

Claim this Profile
M
MicroRNAs are suitable for assessment as biomarkers from formalin-fixed paraffin-embedded tissue, and miR-24 represents an appropriate reference microRNA for diffuse large B-cell lymphoma studies.
Rachel Emily Culpin, Michal Sieniawski, Stephen John Proctor, Geetha Menon, Tryfonia Mainou-Fowler

J Clin Pathol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone--rituximab refractory patients.
Michal Sieniawski, Shilpa Bhartia, Jennifer Wilkinson, Stephen John Proctor

Leuk Lymphoma· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD31 density is a novel risk factor for patients with B-cell chronic lymphocytic leukaemia.
Tryfonia Mainou-Fowler, Alistair Porteous, Annette Nicolle, Stephen John Proctor, John James Anderson

Int J Oncol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2.
Tryfonia Mainou-Fowler, Lynn Marie Overman, Helen Dignum, Katrina Wood, Stephen Crosier, Stephen John Proctor

Int J Oncol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis